|1.||Newman, Amy Hauck: 12 articles (08/2015 - 06/2005)|
|2.||Sokoloff, Pierre: 7 articles (01/2014 - 06/2003)|
|3.||Le Foll, Bernard: 6 articles (01/2016 - 01/2005)|
|4.||Gardner, Eliot L: 5 articles (02/2014 - 11/2002)|
|5.||Gyertyán, István: 5 articles (11/2008 - 01/2003)|
|6.||Xi, Zheng-Xiong: 4 articles (08/2015 - 07/2005)|
|7.||Keck, Thomas M: 4 articles (08/2015 - 01/2014)|
|8.||Nader, Michael A: 4 articles (07/2015 - 06/2005)|
|9.||Luedtke, Robert R: 4 articles (08/2014 - 08/2007)|
|10.||Banala, Ashwini K: 3 articles (08/2015 - 08/2012)|
|1.||Schizophrenia (Dementia Praecox)
03/01/2015 - "Antagonism of the dopamine D3 receptor has been hypothesized to be beneficial for schizophrenia cognitive deficits, negative symptoms and extrapyramidal symptoms. "
04/01/2008 - "The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis."
06/01/2005 - "In this study, the authors investigated the relationship between the Ser9Gly (SG) polymorphism of the dopamine D3 receptor (DRD3) and striatal habit learning in healthy controls and patients with schizophrenia. "
03/01/2003 - "Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis."
06/01/2001 - "Two molecular genetic studies were undertaken to investigate the association between a ser-9-gly polymorphism in the dopamine D3 receptor gene and schizophrenia. "
|2.||Substance-Related Disorders (Drug Abuse)
02/01/2014 - "Preclinical studies suggest that dopamine D3 receptor (D3R) antagonists are promising for the treatment of drug abuse and addiction. "
10/15/2003 - "Recent studies point out the important role of dopamine D3 receptors in drug addiction. "
07/20/2001 - "Recent studies have fueled the interest in dopamine D3 receptor antagonists and partial agonist for the treatment of psychosis and drug abuse, respectively. "
07/22/1999 - "Converging pharmacological, human post-mortem and genetic studies implicate the dopamine D3 receptor in drug addiction. "
07/01/1998 - "Anatomical, pharmacological and human post-mortem studies suggest the dopamine D3 receptor (DRD3) gene as a candidate for drug dependence. "
|3.||Parkinson Disease (Parkinson's Disease)
01/01/2016 - "In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease."
04/01/2015 - "Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors."
01/01/2014 - "Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits."
10/01/2008 - "Clinical improvements in Parkinson's disease produced by dopamine D3 receptor-preferring agonists have been related to their neuroprotective actions and, more recently, to their neuroregenerative properties. "
02/01/2007 - "Dopamine D3 receptor agonists for protection and repair in Parkinson's disease."
|4.||Alcoholism (Alcohol Abuse)
03/01/2008 - "The dopaminergic system has long featured in alcoholism research; hitherto disappointing results from clinical studies could improve following the discovery that dopamine D3 receptor antagonism produces consistent and robust results in preclinical studies. "
06/01/2014 - "In vivo imaging of cerebral dopamine D3 receptors in alcoholism."
01/01/2014 - "Several polymorphisms of the dopamine D3 receptor (DRD3) gene are reported to be involved in the susceptibility to alcoholism. "
06/01/2005 - "Dopamine D3 receptors present an attractive target for alcoholism therapy since they are involved in the mechanisms of alcohol dependency and abuse."
07/26/1996 - "These results strongly suggest that the dopamine D3 receptor is not associated with alcoholism."
|5.||Movement Disorders (Movement Disorder)
01/17/2012 - "The dopamine D3 receptor gene (DRD3) is considered being one of the candidate genes contributing to the development of tardive dyskinesia (TD). "
01/01/2004 - "The association between the dopamine D3 receptor (DRD3) ser9gly genetic polymorphism and tardive dyskinesia (TD), a serious adverse motor disorder after long-term antipsychotic treatment, has been studied extensively in recent years. "
08/01/2002 - "Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics."
07/01/2002 - "Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism."
02/01/2002 - "Tardive dyskinesia is a chronic adverse effect of anti psychotic drugs, where association with a polymorphic site in the dopamine D3 receptor gene has been previously reported. "
|2.||5-HT2A Serotonin Receptor (5 HT2A Receptor)
|3.||Risperidone (Risperdal Consta)
|6.||Dopamine Agonists (Dopamine Agonist)
|7.||Dopamine Receptors (Dopamine Receptor)
|9.||Dopamine D2 Receptors (Dopamine D2 Receptor)
|10.||Brain-Derived Neurotrophic Factor (BDNF)
|1.||Drug Therapy (Chemotherapy)
|3.||Self Administration (Administration, Self)